A meta-analysis of 13 studies showed increased visfatin concentrations in participants with overt obesity, T2DM, metabolic syndrome, and cardiovascular diseases, which were positively associated with insulin resistance22. The gene discussed is NAMPT; the disease is cardiovascular disorder.